行情

EBS

EBS

Emergent Bio
NYSE

实时行情|Nasdaq Last Sale

54.91
+0.74
+1.37%
盘后: 54.91 0 0.00% 16:00 10/18 EDT
开盘
53.99
昨收
54.17
最高
55.18
最低
53.99
成交量
27.45万
成交额
--
52周最高
73.89
52周最低
39.11
市值
28.33亿
市盈率(TTM)
-125.2223
分时
5日
1月
3月
1年
5年

分析师评级

9位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

EBS 新闻

  • 民主党议员:需调查特朗普发表言论前的期货交易
  • 新浪美股.1小时前
  • 英国“脱欧”在即 欧洲车企纷纷准备“撤退”
  • 新浪财经综合.1小时前
  • 特朗普为LV在美工厂剪彩:“法国是美国最老的盟友”
  • 澎湃新闻.2小时前
  • 更省钱:特斯拉正在调整保证金、退换货政策
  • 新浪财经综合.2小时前

更多

所属板块

制药
-0.90%
制药与医学研究
-0.94%

热门股票

名称
价格
涨跌幅

EBS 简况

Emergent BioSolutions Inc. is a life sciences company. The Company focuses on protecting and enhancing life by providing specialty products for civilian and military populations that address accidental, intentional and naturally emerging public health threats. It focuses on developing, manufacturing and commercializing medical countermeasures that address public health threats (PHTs). The PHTs operates through two categories: Chemical, Biological, Radiological and Nuclear, as well as explosive-related threats and emerging infectious diseases. It operates through four business units: Vaccines and Anti-infectives; Antibody Therapeutics; Devices, and Contract Manufacturing. Vaccines and Anti-infectives business unit consists of BioThrax, which is for the general use prophylaxis and post-exposure prophylaxis of anthrax disease. Devices business unit consists of marketed products, such as Reactive Skin Decontamination Lotion Kit (RSDL) and Trobigard (atropine sulfate, obidoxime chloride).
展开

Webull提供Emergent Biosolutions Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。